Dermatology consultation reduces interruption of oncologic management among hospitalized patients with immune-related adverse events: A retrospective cohort study - 13/03/20
Doi : 10.1016/j.jaad.2019.09.026
Steven T. Chen, MD, MPH, MS-HPEd a, b, c, ⁎ 
, Gabriel E. Molina, BA a, b, Jennifer A. Lo, MD, PhD a, b, Sienna Durbin, BS a, Justine V. Cohen, DO a, c, d, Kerry L. Reynolds, MD a, c, d, Daniela Kroshinsky, MD, MPH a, b
, Gabriel E. Molina, BA a, b, Jennifer A. Lo, MD, PhD a, b, Sienna Durbin, BS a, Justine V. Cohen, DO a, c, d, Kerry L. Reynolds, MD a, c, d, Daniela Kroshinsky, MD, MPH a, b a Harvard Medical School, Boston, Massachusetts
b Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts
c Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
d Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts
∗Correspondence to: Steven T. Chen, MD, MPH, 50 Staniford St, 2nd Floor, Boston, MA 0211450 Staniford St2nd FloorBostonMA02114
| A preliminary version of this study was presented as a poster at the International Investigative Dermatology Meeting of the Society for Investigative Dermatology, Orlando, FL, May 17, 2018. |
|
| Dr Chen and Mr Molina are cofirst authors; Drs Reynolds and Kroshinsky are cosenior authors. |
|
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Approved by the Partners Human Research Committee, the institutional review board of Partners HealthCare. |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 4
P. 994-996 - avril 2020 Retour au numéro
Article précédent
- Cardiotoxicity associated with immune checkpoint inhibitors in cutaneous oncology
- Mika M. Tabata, Sara Choi, Kelsey Hirotsu, Bernice Kwong, Teo Soleymani
- Belatacept reduces skin cancer risk in kidney transplant recipients
- Mike Wang, Amit Mittal, Oscar R. Colegio
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?